Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ibuprofen
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Geisinger Clinic | National Institute on Drug Abuse
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ibuprofen is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Opioid-Related Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 08, 2019
Lead Product(s) : Ibuprofen
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Geisinger Clinic | National Institute on Drug Abuse
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fentanyl
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Recipient : University of California, Los Angeles
Deal Size : Inapplicable
Deal Type : Inapplicable
Coronary Angiography THerapeutic Virtual Reality
Details : Fentanyl is a Controlled Substance drug candidate, which is currently being evaluated in clinical studies for the treatment of Atherosclerosis.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
April 06, 2018
Lead Product(s) : Fentanyl
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Recipient : University of California, Los Angeles
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
